144 related articles for article (PubMed ID: 35820631)
1. PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
Bouzoni E; Perakakis N; Connelly MA; Angelidi AM; Pilitsi E; Farr O; Stefanakis K; Mantzoros CS
Metabolism; 2022 Sep; 134():155265. PubMed ID: 35820631
[TBL] [Abstract][Full Text] [Related]
2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers.
Wong Chong E; Joncas FH; Seidah NG; Calon F; Diorio C; Gangloff A
BMC Cancer; 2022 Oct; 22(1):1049. PubMed ID: 36203122
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans.
Pilitsi E; Peradze N; Perakakis N; Mantzoros CS
Metabolism; 2019 Aug; 97():32-39. PubMed ID: 31103608
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.
Wong Chong E; Joncas FH; Douville P; Bachvarov D; Diorio C; Calon F; Bergeron AC; Blais J; Leung SOA; Seidah NG; Gangloff A
Lipids Health Dis; 2024 Feb; 23(1):59. PubMed ID: 38414008
[TBL] [Abstract][Full Text] [Related]
6. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
Mulligan K; Khatami H; Schwarz JM; Sakkas GK; DePaoli AM; Tai VW; Wen MJ; Lee GA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1137-44. PubMed ID: 19174500
[TBL] [Abstract][Full Text] [Related]
7. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
[TBL] [Abstract][Full Text] [Related]
8. Leptin in congenital and HIV-associated lipodystrophy.
Tsoukas MA; Farr OM; Mantzoros CS
Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
[TBL] [Abstract][Full Text] [Related]
9. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
[TBL] [Abstract][Full Text] [Related]
10. Leptin in relation to the lipodystrophy-associated metabolic syndrome.
Mantzoros CS
Diabetes Metab J; 2012 Jun; 36(3):181-9. PubMed ID: 22737657
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease.
Zhao Z; Fu Y; Lian H; Liu Y; Liu J; Sun L; Zhang Y
Clin Cardiol; 2024 Feb; 47(3):e24246. PubMed ID: 38425231
[TBL] [Abstract][Full Text] [Related]
12. Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line.
Rossi I; Marodin G; Lupo MG; Adorni MP; Papotti B; Dall'Acqua S; Ferri N
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612519
[TBL] [Abstract][Full Text] [Related]
13. Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.
Muniyappa R; Abel BS; Asthana A; Walter MF; Cochran EK; Remaley AT; Skarulis MC; Gorden P; Brown RJ
J Clin Lipidol; 2017; 11(2):543-550. PubMed ID: 28502512
[TBL] [Abstract][Full Text] [Related]
14. Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation.
Athyros VG; Katsiki N; Dimakopoulou A; Patoulias D; Alataki S; Doumas M
Curr Pharm Des; 2018; 24(31):3638-3646. PubMed ID: 30306859
[TBL] [Abstract][Full Text] [Related]
15. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
[TBL] [Abstract][Full Text] [Related]
16. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
[TBL] [Abstract][Full Text] [Related]
17. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
[TBL] [Abstract][Full Text] [Related]
18. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans.
Brennan AM; Lee JH; Tsiodras S; Chan JL; Doweiko J; Chimienti SN; Wadhwa SG; Karchmer AW; Mantzoros CS
Eur J Endocrinol; 2009 Feb; 160(2):173-6. PubMed ID: 19029226
[TBL] [Abstract][Full Text] [Related]
19. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
20. Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study.
Foss-Freitas MC; Akinci B; Neidert A; Bartlett VJ; Hurh E; Karwatowska-Prokopczuk E; Oral EA
Lipids Health Dis; 2021 Dec; 20(1):174. PubMed ID: 34865644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
